Pfizer inks $43 billion Seagen deal to boost cancer portfolio

Pfizer buys Seagen Inc. for $43 bln, boosts access to cancer drugs

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.The

Pfizer buys Seagen for $43B, boosts access to cancer drugs

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.

Pfizer buys Seagen for $43B, boosts access to cancer drugs | Chattanooga Times Free Press

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.

Pfizer buys Seagen for $43B, boosts access to cancer drugs

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.

Pfizer buys the cancer company Seagen for 40 billion euros

Pfizer announced on Monday the acquisition of Seagen, a biotechnology company that researches cancer drugs, for a total of 43 billion dollars (about 40 billion euros).” Pfizer is deploying its financial resources to advance the battle against cancer, one of the main...

Pfizer buys biotech firm Seagen for $43 billion

WASHINGTON: US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.Pfizer is offering...